MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MBLY • US60741F1049

8.4 USD
-0.53 (-5.94%)
At close: Feb 5, 2026
8.36 USD
-0.04 (-0.48%)
Pre-Market: 2/6/2026, 8:10:14 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MBLY. MBLY was compared to 42 industry peers in the Automobile Components industry. No worries on liquidiy or solvency for MBLY as it has an excellent financial health rating, but there are worries on the profitability. MBLY is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year MBLY was profitable.
  • MBLY had a positive operating cash flow in the past year.
  • MBLY had negative earnings in each of the past 5 years.
  • MBLY had a positive operating cash flow in each of the past 5 years.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -1B -2B -3B

1.2 Ratios

  • The Return On Assets of MBLY (-2.69%) is worse than 61.90% of its industry peers.
  • Looking at the Return On Equity, with a value of -2.82%, MBLY is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

1.3 Margins

  • With an excellent Gross Margin value of 48.66%, MBLY belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MBLY has grown nicely.
  • The Profit Margin and Operating Margin are not available for MBLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.09%
GM growth 5Y4.19%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

  • MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • MBLY has an Altman-Z score of 7.40. This indicates that MBLY is financially healthy and has little risk of bankruptcy at the moment.
  • MBLY's Altman-Z score of 7.40 is amongst the best of the industry. MBLY outperforms 83.33% of its industry peers.
  • There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.4
ROIC/WACCN/A
WACC8.73%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • MBLY has a Current Ratio of 6.46. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
  • MBLY's Current ratio of 6.46 is amongst the best of the industry. MBLY outperforms 92.86% of its industry peers.
  • A Quick Ratio of 5.61 indicates that MBLY has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 5.61, MBLY belongs to the top of the industry, outperforming 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.46
Quick Ratio 5.61
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

7

3. Growth

3.1 Past

  • MBLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.00%, which is quite impressive.
  • The Revenue has grown by 14.51% in the past year. This is quite good.
  • Measured over the past years, MBLY shows a quite strong growth in Revenue. The Revenue has been growing by 14.39% on average per year.
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)14.51%
Revenue growth 3Y0.44%
Revenue growth 5Y14.39%
Sales Q2Q%-8.98%

3.2 Future

  • MBLY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.82% yearly.
  • Based on estimates for the next years, MBLY will show a very strong growth in Revenue. The Revenue will grow by 30.67% on average per year.
EPS Next Y10.76%
EPS Next 2Y27.49%
EPS Next 3Y44.56%
EPS Next 5Y51.82%
Revenue Next Year4.9%
Revenue Next 2Y9.93%
Revenue Next 3Y15.07%
Revenue Next 5Y30.67%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 23.33, MBLY is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of MBLY is on the same level as its industry peers.
  • MBLY is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 21.07, the valuation of MBLY can be described as rather expensive.
  • MBLY's Price/Forward Earnings is on the same level as the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. MBLY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 23.33
Fwd PE 21.07
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MBLY is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
  • Based on the Price/Free Cash Flow ratio, MBLY is valued a bit cheaper than 76.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.88
EV/EBITDA 34.58
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MBLY does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as MBLY's earnings are expected to grow with 44.56% in the coming years.
PEG (NY)2.17
PEG (5Y)N/A
EPS Next 2Y27.49%
EPS Next 3Y44.56%

0

5. Dividend

5.1 Amount

  • MBLY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (2/5/2026, 8:00:01 PM)

Premarket: 8.36 -0.04 (-0.48%)

8.4

-0.53 (-5.94%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)01-22
Earnings (Next)04-22
Inst Owners75.91%
Inst Owner Change-3.96%
Ins Owners2.17%
Ins Owner Change1.15%
Market Cap6.84B
Revenue(TTM)1.89B
Net Income(TTM)-336.00M
Analysts74.71
Price Target19.51 (132.26%)
Short Float %17.3%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.99%
Min EPS beat(2)2.78%
Max EPS beat(2)23.2%
EPS beat(4)4
Avg EPS beat(4)11.44%
Min EPS beat(4)2.78%
Max EPS beat(4)23.2%
EPS beat(8)7
Avg EPS beat(8)7.16%
EPS beat(12)11
Avg EPS beat(12)15.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.92%
Min Revenue beat(2)2.68%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)7
Avg Revenue beat(12)0.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.42%
PT rev (3m)-0.6%
EPS NQ rev (1m)-1.12%
EPS NQ rev (3m)9.64%
EPS NY rev (1m)-5.18%
EPS NY rev (3m)-9.19%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)2.73%
Revenue NY rev (1m)-2.42%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 23.33
Fwd PE 21.07
P/S 3.53
P/FCF 10.88
P/OCF 9.86
P/B 0.57
P/tB 2.78
EV/EBITDA 34.58
EPS(TTM)0.36
EY4.29%
EPS(NY)0.4
Fwd EY4.75%
FCF(TTM)0.77
FCFY9.19%
OCF(TTM)0.85
OCFY10.14%
SpS2.38
BVpS14.67
TBVpS3.02
PEG (NY)2.17
PEG (5Y)N/A
Graham Number10.9
Profitability
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.66%
FCFM 32.4%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.09%
GM growth 5Y4.19%
F-Score6
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 12.65%
Cap/Sales 3.35%
Interest Coverage N/A
Cash Conversion 541.41%
Profit Quality N/A
Current Ratio 6.46
Quick Ratio 5.61
Altman-Z 7.4
F-Score6
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)16.8%
Cap/Depr(5y)19.43%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y10.76%
EPS Next 2Y27.49%
EPS Next 3Y44.56%
EPS Next 5Y51.82%
Revenue 1Y (TTM)14.51%
Revenue growth 3Y0.44%
Revenue growth 5Y14.39%
Sales Q2Q%-8.98%
Revenue Next Year4.9%
Revenue Next 2Y9.93%
Revenue Next 3Y15.07%
Revenue Next 5Y30.67%
EBIT growth 1Y-4.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year40.27%
EBIT Next 3Y42.58%
EBIT Next 5Y45.14%
FCF growth 1Y193.46%
FCF growth 3Y6.33%
FCF growth 5Y23.78%
OCF growth 1Y127.21%
OCF growth 3Y3.31%
OCF growth 5Y17.31%

MOBILEYE GLOBAL INC-A / MBLY FAQ

What is the fundamental rating for MBLY stock?

ChartMill assigns a fundamental rating of 5 / 10 to MBLY.


What is the valuation status for MBLY stock?

ChartMill assigns a valuation rating of 3 / 10 to MOBILEYE GLOBAL INC-A (MBLY). This can be considered as Overvalued.


Can you provide the profitability details for MOBILEYE GLOBAL INC-A?

MOBILEYE GLOBAL INC-A (MBLY) has a profitability rating of 3 / 10.


How financially healthy is MOBILEYE GLOBAL INC-A?

The financial health rating of MOBILEYE GLOBAL INC-A (MBLY) is 8 / 10.


What is the expected EPS growth for MOBILEYE GLOBAL INC-A (MBLY) stock?

The Earnings per Share (EPS) of MOBILEYE GLOBAL INC-A (MBLY) is expected to grow by 10.76% in the next year.